Mustapha Azahaf
Overview
Explore the profile of Mustapha Azahaf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cartier L, Loiez A, Nachury M, Azahaf M, Hambli S, Blondeaux A, et al.
Inflamm Bowel Dis
. 2024 Apr;
31(1):52-62.
PMID: 38597799
Background: Crohn's disease (CD) is a progressive, destructive, and disabling disorder. Our study aimed to assess changes over time in the Lémann index (LI) and the Inflammatory Bowel Disease Disability...
2.
Kouidrat Y, Le Collen L, Vaxillaire M, Dechaume A, Toussaint B, Vaillant E, et al.
Diabetes Metab
. 2023 Dec;
50(1):101507.
PMID: 38141807
Objective: Heterozygous pathogenic or likely pathogenic (P/LP) PDX1 variants cause monogenic diabetes. We comprehensively examined the phenotypes of carriers of P/LP PDX1 variants, and delineated potential treatments that could be...
3.
Vermersch M, Azahaf M, Ernst O
J Magn Reson Imaging
. 2021 Jun;
55(1):138-139.
PMID: 34145675
No abstract available.
4.
Pariente B, Torres J, Burisch J, Arebi N, Barberio B, Duricova D, et al.
Gastroenterology
. 2021 May;
161(3):853-864.e13.
PMID: 34052277
Background & Aims: The Lémann Index is a tool measuring cumulative structural bowel damage in Crohn's disease (CD). We reported on its validation and updating. Methods: This was an international,...
5.
Artru F, Miquet X, Azahaf M, Labreuche J, Wandji L, Sergent G, et al.
Aliment Pharmacol Ther
. 2020 Sep;
52(9):1516-1526.
PMID: 32931618
Background: Body composition may be modified after improvement of portal hypertension (PHT) by transjugular intrahepatic portosystemic shunt (TIPSS) insertion. Aims: To evaluate changes in body composition following TIPSS placement, their...
6.
Lauriot Dit Prevost C, Azahaf M, Nachury M, Branche J, Gerard R, Wils P, et al.
Aliment Pharmacol Ther
. 2020 Mar;
51(9):889-898.
PMID: 32221985
Background: The notion of Crohn's disease (CD) as a chronic, progressive and disabling condition has led to the development of new indexes: the Lémann Index measuring cumulative bowel damage and...
7.
Halle E, Azahaf M, Duveau N, Lambin T, Nachury M, Branche J, et al.
Dig Dis Sci
. 2019 Dec;
65(9):2664-2674.
PMID: 31811438
Background: The aim of the study was to identify factors associated with a radiological response and to assess the impact of radiological improvement in long-term outcomes in small bowel (SB)...
8.
Azahaf M, Haberlay M, Betrouni N, Ernst O, Behal H, Duhamel A, et al.
J Magn Reson Imaging
. 2015 Aug;
43(3):737-49.
PMID: 26303794
Purpose: Using a limited temporal resolution dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) dataset to assess the impact of the arterial input function (AIF) choice on the transfer constant (K(trans)...
9.
Pauwels X, Azahaf M, Lassailly G, Sergent G, Buob D, Truant S, et al.
Cardiovasc Intervent Radiol
. 2014 Oct;
38(3):685-92.
PMID: 25342136
Purpose: Most transplant centers use chemoembolisation as locoregional bridge therapy for hepatocellular carcinoma (HCC) before liver transplantation (LT). Chemoembolisation using beads loaded with doxorubicin (DEBDOX) is a promising technique that...
10.
Tartare G, Hamad D, Azahaf M, Puech P, Betrouni N
Comput Med Imaging Graph
. 2014 Sep;
38(8):702-13.
PMID: 25179917
Dynamic contrast-enhanced (DCE)-magnetic resonance imaging (MRI) represents an emerging method for the prediction of biomarker responses in cancer. However, DCE images remain difficult to analyze and interpret. Although pharmacokinetic approaches,...